Sessions

Sessionsort ascending Date
Division of Hematologic Malignancies & Cellular Therapy Updates Part 1 09/13/2023 - 8:00am to 9:00am EDT
Developments in the Management of Early-Stage Resectable NSCLC without Targetable Mutations & An unusual case of lung cancer: MALT lymphoma in a young 12/06/2023 - 8:00am to 9:00am EST
Circulating Tumor DNA as a Non-Invasive Biomarker in Solid Tumor Oncology 04/05/2023 - 8:00am to 9:00am EDT
CAR T-Cell Therapy for Pediatric B-ALL 05/17/2023 - 8:00am to 9:00am EDT
Breaking Bad B Cells: Identifying Novel Targets in Chronic GVHD 01/04/2023 - 8:30am to 9:00am EST
Atlas of Blood Cancer Genomes: Our 10,000 Patient Odyssey To Personalized Genomics 01/18/2023 - 8:00am to 9:00am EST
Acquired von Willebrand syndrome / Immunotherapy or hospice? 06/21/2023 - 8:00am to 9:00am EDT
A Role for Androgen Receptor in Hepatocellular Carcinoma & Vanishing Biomarker: A Case of HER2-positive Early Breast Cancer 10/18/2023 - 8:00am to 9:00am EDT
A Review on Factor XI Inhibitors and Potential for Treatment of Cancer-Associated Thrombosis / Acute Promyelocytic Leukemia: Historical awareness, Building Trust and Empowering Patients 06/14/2023 - 8:00am to 9:00am EDT
A Rare Treatment Related Toxicity in Multiple Myeloma - A Case Study and Brief Literature Review/A case-based discussion of POEMS syndrome 12/20/2023 - 8:00am to 9:00am EST

Pages